Peptinovo Biopharma

Ann Arbor, MI

Peptinovo Biopharma Inc. has invented and patented a targeted, drug-delivery platform: Peptide-Amphiphile Lipid Micelle (PALM) that reduces or eliminates chemotherapy-induced peripheral neuropathy (CIPN), one of the most serious side effects threatening treatment outcomes for world-leading chemotherapy drugs like paclitaxel.

Company Details

Founded: 2014
Employees: Between 5 - 10 employees
Raised: $1,297,885
Headquarters Location: Ann Arbor, MI
Public: No
Acquired: No
CEO: Steve Tokarz
Founders: Bill Elliott
Ren Homan

Company Collections

These are collections Peptinovo Biopharma is a part of. Click on the collection name to view similar companies.

Peptinovo Biopharma's Industries

Software Companies

Medical Organizations

Health Care Companies

Biotechnology Companies

Peptinovo Biopharma's Tech Stack

Peptinovo Biopharma Headquarters Location

600 S Wagner Rd, Ann Arbor, MI 48103-9002

Total Amount Raised: $1,297,885

Peptinovo Biopharma Funding Rounds

Series Unknown
$1,297,885
Sep 23, 2024

Funding info provided by Diffbot.

Peptinovo Biopharma Reviews

Based on 0 reviews

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Peptinovo Biopharma.